Lv51
1018 积分 2022-08-30 加入
Glucagon-like Peptide-1 Receptor Agonists Are Associated With Improved Survival and Reduced Liver-Related Events in Patients With Type 2 Diabetes and Metabolic Dysfunction-Associated Liver Disease: A Large Real-World Retrospective Study
4小时前
求助中
Multi-organ proteomic atlas of obesity regression in male mice
4小时前
已完结
Incidence of Cirrhosis in Fibrotic Metabolic Dysfunction-Associated Steatohepatitis: A Meta-Analysis of Placebo Arms from Randomized Clinical Trials
5天前
已完结
Characteristics of contemporary drug clinical trials regarding the treatment of non-alcoholic steatohepatitis
5天前
已完结
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo
10天前
已完结
Meta‐analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis ( MASH )
1个月前
已完结
Efficacy and safety of aldafermin for the treatment of metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
2个月前
已完结
Early Real‐World Implementation of Once‐Weekly Insulin Icodec in Type 2 Diabetes
2个月前
已完结
Vascular Effects of Insulin and Their Relation to Endothelial Dysfunction, Insulin Resistance and Hypertension
3个月前
已完结
A review of survodutide: a new dual acting agonist
4个月前
已关闭
皖公网安备34019202002308
